Editorial by Christian G. Brilla
Cardiovascular Research 47 (2000) 1–3
www.elsevier.com/locate/cardiores
www.elsevier.nl/locate/cardiores
Editorial
Renin–angiotensin–aldosterone system and myocardial ﬁbrosis
* Christian G. Brilla
Center of Internal Medicine, Division of Cardiology, Philipps University of Marburg, Marburg, Germany
Received 30 March 2000; accepted 5 April 2000
See article by Bishop et al. [26] (pages 57–67) in this pacing in dogs, were associated with activation of RAAS
issue. and progressive increase in preload. There, myocardial
ﬁbrosis was seen in either ventricle [14]. On the other
During the past decade, evidence has been provided that hand, myocardial ﬁbrosis was not seen in cardiac hy-
the circulating and local renin–angiotensin–aldosterone pertrophy that accompanies volume overload states due to
systems (RAAS) promote the development of myocardial chronic anemia, an arteriovenous ﬁstula, or atrial septal
ﬁbrosis in hypertensive heart disease and chronic heart defect [15,16], i.e., states where RAAS is not upregulated.
failure [1,2] including in vitro experiments using adult rat These ﬁndings suggest that the growth of cellular con-
cardiac ﬁbroblasts where both angiotensin II (AngII) [3–5] stituents of the various myocardial tissue compartments,
and aldosterone [3] stimulate collagen synthesis in a dose- namely cardiac myocytes and ﬁbroblasts, which are re-
dependent manner while AngII additionally suppresses the sponsible for myocardial collagen metabolism, may each
activity of matrix metalloproteinase 1, the key enzyme of have different regulatory mechanisms. In contrast to load-
interstitial collagen degradation [3], that synergistically dependent growth of cardiac myocytes, mechanical factors
leads to progressive collagen accumulation within the would not appear to account for the disproportionate
myocardial interstitium. This could be proved in in vivo accumulation of collagen that occurs with LVH in some
studies in renovascular hypertension [1], with chronic conditions and not others despite comparable elevations in
administration of aldosterone [1,6,7], or in the sponta- wall stress due to chronic pressure or volume overload of
neously hypertensive rat (SHR) model of genetic hyperten- the left ventricle. Moreover, types I and III collagen gene
sion [8–12] where a local cardiac AngII generating system expression and collagen synthesis are temporally disso-
is operative [13]. Therefore, the physiological role of ciated from the onset of myocyte growth [17]. Thus,
RAAS on the development of myocardial ﬁbrosis could be trophic factors which mediate myocyte and nonmyocyte
established. In particular, in various models of experimen- (i.e., cardiac ﬁbroblast) cell growth of the myocardium can
tal hypertension with comparable degrees of elevated be independent of one another. In arterial hypertension or
systolic arterial pressure and left ventricular hypertrophy heart failure, reactive myocardial ﬁbrosis which is not
(LVH), myocardial ﬁbrosis was found only in the presence secondary to myocyte necrosis was associated with RAAS
of stimulated circulating RAAS, i.e., in renovascular activation irrespective of the hemodynamic load. Thus, it
hypertension, or when aldosterone was chronically infused appears, that RAAS plays a major physiological role in
via subcutaneously implanted osmotic minipumps to raise regulating the myocardial extracellular matrix. Indeed, a
plasma aldosterone levels as seen in congestive heart large body of evidence has been provided that angiotensin-
failure. There, interstitial and perivascular ﬁbrosis was converting enzyme (ACE) inhibitors, such as enalapril,
found in either ventricle, the pressure-overloaded, hy- lisinopril and trandolapril, regress myocardial ﬁbrosis in
pertrophied left ventricle and the non-overloaded, not SHR associated with reduction of ventricular arrhythmias
hypertrophied right ventricle [1]. In contrast, myocardial and improvement of myocardial function [9–11,18,19]
ﬁbrosis was absent in either ventricle of hypertensive rats irrespective of antihypertensive effects [9]. Finally, those
with infrarenal aortic band where RAAS was not activated experimental ﬁndings could be conﬁrmed in patients with
although LVH was present [1]. hypertensive heart disease due to primary hypertension
Furthermore, low output heart failure models, like rapid where the ACE inhibitor lisinopril proved to regress
myocardial ﬁbrosis along with improvement of left ven-
tricular diastolic dysfunction [20]. *Tel.: 149-6421-286-4980; fax: 149-6421-286-8954.
E-mail address: brilla@t-online.de (C.G. Brilla) Other antihypertensive drugs, e.g., atenolol [21], minox-
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idil [22], a-methyldopa [23], hydrochlorothiazide [20] or Dawley controls. Therefore, this model does not appear to
hydralazine [24] have failed to show any signiﬁcant effect be appropriate to sort out the inﬂuence of local cardiac
on regression of myocardial ﬁbrosis or even increased RAAS on myocardial structure because cardiac RAAS
myocardial collagen concentration in experimental models appears to be not stimulated compared with normotensive
of arterial hypertension although blood pressure was well Sprague–Dawley control rats and any further suppression
controlled. In contrast, studies with the aldosterone antago- of cardiac RAAS may not have any relevance. Although
nist spironolactone in the rat with either unilateral renal this transgenic rat line represents a monogenetic model of
ischemia or hyperaldosteronism have shown that it is hypertension the actual mechanisms responsible for elevat-
possible to even prevent the ﬁbrous tissue response [6,7]. ing blood pressure remains unclear. The cause of high
Rats with either renovascular hypertension or primary blood pressure is clearly not an overexpression of renin in
hyperaldosteronism were pretreated with small or large the kidneys and the suppression of plasma and kidney
doses of spironolactone. The smaller dose did not prevent renin is certainly a secondary event to elevated blood
hypertension or LVH, while the larger dose did.With either pressure.
dose of spironolactone, however, the interstitial and It appears that tissue RAAS of the adrenal glands is of
perivascular ﬁbrosis was not seen [25]. What we have primary importance in this model. Such a perception is
learned from those pharmacological intervention trials is supported by ﬁndings that production and secretion of
that normalization of blood pressure is not necessarily adrenocortical 18-hydroxylated steroids, i.e., 18-hydroxy-
associated with regression or prevention of myocardial 11-deoxycorticosterone, 18-hydroxycorticosterone, and al-
ﬁbrosis and reduction of ﬁbrous tissue in the myocardium dosterone are elevated [29] associated with hypertrophy of
may occur irrespective of normalization of elevated blood zona glomerulosa cells and enhanced urinary aldosterone
pressure, and that local or circulating RAAS is of primary excretion [27]. Since mineralocorticoids like aldosterone
regulatory importance for the remodeling of the cardiac are known to promote myocardial ﬁbrosis [1,6,7,25] the
extracellular matrix. ﬁbrotic myocardium of TGR rats could ﬁnd a reasonable
In the paper by Bishop et al. in this issue of Car- explanation irrespective of the absence of stimulated
diovascular Research [26], the transgenic (mREN2)27 rat cardiac RAAS. As soon as AngII type 1 receptors of zona
(TGR) model was used to separate the role of cardiac glomerulosa cells are blocked or adrenal ACE is inhibited
tissue RAAS and blood pressure on myocardial structure. in TGR rats the ﬁbrotic tissue response of other organs like
Driven by the hypothesis that high blood pressure per se the heart could be abolished where AngII is a major
represents an important stimulus for the development of stimulator for adrenal aldosterone synthesis and trophic
myocardial ﬁbrosis, Bishop et al. found that 20-week responses to mineralocorticoids depend on the distribution
treatment of TGR rats with high doses of the ACE of corticoid type I receptors which are present in the heart.
inhibitor ramipril prevented the occurrence of myocardial The fulminant hypertension of TGR rats might be caused
ﬁbrosis along with normalization of blood pressure while by overexpression of both adrenal and local vascular
low doses of ramipril neither affected blood pressure nor RAAS [30].
ﬁbrosis although plasma and cardiac ACE activities were In conclusion, the TGR model appears to be primarily a
signiﬁcantly reduced that nicely supported their hypoth- model of overexpressed adrenal RAAS with endocrine
esis. However, they found as well that 12-week treatment effects on myocardial structure and does not serve the
with the calcium channel blocker amlodipine did not purpose of focusing on local cardiac RAAS which is not
normalize blood pressure, i.e., it remained signiﬁcantly stimulated in this model. Best suited for assessing the
elevated above control, while myocardial ﬁbrosis could be detrimental inﬂuence of RAAS on myocardial collagen
prevented that did not support their hypothesis like a broad matrix remodeling is still the 2-kidney-1-clip model of
list of literature reviewed above. renovascular hypertension in the rat which is associated
The transgenic rat line bearing the murine Ren-2 renin with a marked release of renin, the key enzyme of RAAS.
gene cloned from the DBA/2J mouse strain is thought to Within days of inducing renovascular hypertension by
provide a monogenic model of hypertension in which the unilateral renal ischemia, type I and III collagen gene
genetic basis, i.e., the additional murine renin gene, is expression is increased [17] and progressive myocardial
known [27]. Heterozygous animals as used in the study by ﬁbrosis is known to occur [8–11,31]. This type of ﬁbrosis
Bishop et al. are characterized by severe hypertension, is termed reactive ﬁbrosis (versus reparative ﬁbrosis or
unchanged or even suppressed plasma concentrations of scarring), because it is not secondary due to myocyte
angiotensinogen, active renin, AngI, and AngII compared necrosis [31]. At 8 weeks of renovascular hypertension in
with transgene-negative littermates. On the tissue level, the rat, diffuse perivascular and interstitial ﬁbrosis leads to
renin is suppressed in the kidneys and murine renin is an increase in collagen volume fraction of the hyper-
expressed at very high levels in the adrenal glands [27] trophied left ventricle by threefold [1], at 12 weeks by
while cardiac AngI and AngII concentrations are reduced fourfold [31], and at 32 weeks by sixfold above control
[28]. In Bishop’s study, no signiﬁcant difference of cardiac [32]. At the early stage of renovascular hypertension,
ACE activity was found in TGR compared with Sprague– myocardial diastolic stiffness and contractility are each
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